查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1787231

全球神经栓塞设备市场

Neurovascular Embolization Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球神经栓塞设备市场规模将达到 15 亿美元

全球神经血管栓塞装置市场规模预计在2024年达到12亿美元，预计在2024-2030年的分析期内将以4.6%的复合年增长率增长，到2030年将达到15亿美元。栓塞线圈是本报告分析的细分市场之一，预计其复合年增长率为3.6%，到分析期结束时市场规模将达到5.796亿美元。血流改道装置细分市场在分析期间的复合年增长率预计为3.8%。

美国市场规模估计为 3.154 亿美元，中国市场预计复合年增长率为 7.1%

美国神经栓塞器材市场规模预计在2024年达到3.154亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到2.94亿美元，在分析期间（2024-2030年）的复合年增长率为7.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为2.2%和4.6%。在欧洲，德国的复合年增长率预计为2.9%。

全球神经栓塞设备市场—主要趋势与驱动因素摘要

为什么神经栓塞装置对于治疗中风和动脉瘤至关重要？

神经血管栓塞装置已成为颅内动脉瘤、动静脉畸形 (AVM) 和其他脑血管异常治疗的重要组成部分。微创装置，例如栓塞线圈、液体栓塞剂、血流转向器和血管栓塞，旨在防止动脉瘤破裂、减少流向异常血管的血流并稳定脑循环。随着中风和出血性疾病成为全球致残和死亡的主要原因，神经血管栓塞已成为开颅手术和夹闭术等传统外科手术介入的有效替代方案。血管内治疗的进展显着改善了患者的预后，缩短了復原时间并减少了治疗后併发症。尤其是血流转向器，已成为治疗以前被认为无法手术的复杂宽颈颈部的突破性技术。此外，液体栓塞剂透过精确闭塞血管并降低復发性出血的风险，正在彻底改变 AVM 的治疗。随着全球神经血管疾病负担的增加，对栓塞装置的需求也在增加，推动了介入神经放射学治疗的进一步技术创新和应用。

哪些挑战阻碍了神经栓塞装置的普及？

儘管神经栓塞装置的疗效已得到证实，但仍有几个挑战阻碍了其广泛应用。一个主要问题是血管内栓塞的高成本，限制了其在医疗资源有限地区的普及。此外，栓塞技术复杂，需要训练有素的介入神经放射学，限制了其在农村地区和医疗体係不发达地区应用。另一个主要挑战是手术併发症的风险，包括血管穿孔、缺血和栓塞物质移位，这些併发症可能导致中风和神经病变。此外，患者解剖和血管状况的多变性需要个别化治疗计划，这需要先进的影像学检查和广泛的术前评估。新栓塞技术的监管障碍和漫长的核准週期进一步减缓了市场扩张，并推迟了获得下一代神经血管治疗的机会。此外，患者对微创神经血管介入的认识仍然很低，导致诊断延迟和栓塞治疗利用不足。应对这些挑战需要加强对医生培训的投资，提高设备的安全性和准确性，并加强努力使栓塞治疗更加普及且价格更实惠。

技术创新如何提高神经栓塞装置的有效性？

神经血管栓塞领域的技术进步日新月异，提高了手术成功率并扩大了复杂脑血管疾病的治疗选择。其中最重要的创新之一是生物活性栓塞线圈的开发。这些线圈透过促进内皮细胞增生来加速动脉瘤闭塞并促进长期血管癒合。此外，第二代流量转向器的引入提高了灵活性和流量控制能力，提高了治疗大型宽颈部动脉瘤的安全性和有效性。人工智慧驱动的影像和机器人辅助血管内导航的结合实现了精准栓塞，最大限度地降低了併发症的风险，并改善了患者的预后。增强黏度控制的液体栓塞剂也透过提高对目标血管结构的渗透性和黏附性，促进了 AVM 的治疗。此外，联合治疗，例如栓塞后进行神经保护药物干预，进一步优化了神经血管治疗策略。随着设备製造商不断改进栓塞技术，介入神经放射学手术变得更加安全、高效，并且更容易更广泛的患者接受。

是什么推动了神经栓塞设备市场的成长？

神经血管栓塞器械市场的成长受到多种因素的推动，包括脑血管疾病盛行率的上升、微创手术的普及以及血管内治疗技术的不断进步。由于人口老化以及高血压和吸烟等生活方式相关的风险因素，颅内动脉瘤 (AVM) 的发生率不断上升，对有效的神经血管介入治疗的需求也日益旺盛。由于栓塞手术与开放性手术相比，其发生率更低、住院时间更短，因此向微创技术的转变进一步推动了市场扩张。栓塞材料（包括生物可吸收和渗透性线栓塞剂）的技术进步，正在提高手术的准确性和安全性。此外，3D 旋转血管造影术和灌注磁振造影 (MRI) 等先进神经影像技术的日益普及，也透过改进诊断和治疗计划，推动了其应用率的提高。报销政策的扩大以及政府旨在发展中风治疗基础设施的倡议，也在市场成长中发挥关键作用。随着医疗保健提供者和研究机构继续投资于神经血管创新，神经血管栓塞设备市场预计将大幅扩大，为患有复杂脑血管疾病的患者提供挽救生命的解决方案。

部分

产品类型（栓塞线圈、血流改道装置、液体栓塞剂、动脉瘤夹）、最终用户（医院最终用户、专科诊所最终用户、其他最终用户）

受访公司范例

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.（CERENOVUS）
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.（Terumo Corporation）
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP32332

Global Neurovascular Embolization Devices Market to Reach US$1.5 Billion by 2030

The global market for Neurovascular Embolization Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Embolic Coils, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$579.6 Million by the end of the analysis period. Growth in the Flow Diversion Devices segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.4 Million While China is Forecast to Grow at 7.1% CAGR

The Neurovascular Embolization Devices market in the U.S. is estimated at US$315.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$294.0 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Neurovascular Embolization Devices Market - Key Trends & Drivers Summarized

Why Are Neurovascular Embolization Devices Essential in Stroke and Aneurysm Treatment?

Neurovascular embolization devices have become critical in the management of intracranial aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular abnormalities. These minimally invasive devices, including embolic coils, liquid embolic agents, flow diverters, and vascular plugs, are designed to prevent aneurysm rupture, reduce blood flow to abnormal vessels, and stabilize cerebral circulation. With stroke and hemorrhagic conditions being leading causes of disability and mortality worldwide, neurovascular embolization procedures are gaining traction as an effective alternative to traditional surgical interventions such as craniotomy and clipping. The advancement of endovascular techniques has significantly improved patient outcomes, reducing recovery times and post-procedural complications. In particular, flow diverters have emerged as a game-changing technology for treating wide-necked and complex aneurysms that were previously considered inoperable. Additionally, liquid embolic agents are revolutionizing AVM treatment by allowing precise vessel occlusion, reducing the risk of recurrent hemorrhage. As the global burden of neurovascular diseases rises, the demand for embolization devices is increasing, driving further innovation and adoption in neurointerventional procedures.

What Challenges Are Hindering the Adoption of Neurovascular Embolization Devices?

Despite their proven efficacy, several challenges hinder the widespread adoption of neurovascular embolization devices. One of the primary concerns is the high cost of endovascular embolization procedures, making them less accessible in regions with limited healthcare funding. Additionally, the technical complexity of embolization procedures requires highly trained neurointerventionalists, limiting availability in rural and underdeveloped healthcare systems. Another significant challenge is the risk of procedural complications, including vessel perforation, ischemia, and migration of embolic materials, which can lead to stroke or neurological deficits. The variability in patient anatomy and vascular conditions also necessitates personalized treatment planning, requiring advanced imaging and extensive pre-procedural evaluation. Regulatory hurdles and long approval cycles for new embolization technologies further slow down market expansion, delaying access to next-generation neurovascular treatments. Moreover, patient awareness about minimally invasive neurovascular interventions remains low, leading to delayed diagnosis and underutilization of embolization therapies. Addressing these challenges will require greater investment in physician training, improvements in device safety and precision, and increased efforts to make embolization procedures more widely available and affordable.

How Are Innovations Enhancing the Effectiveness of Neurovascular Embolization Devices?

The field of neurovascular embolization is witnessing rapid technological advancements that are improving procedural success rates and expanding treatment options for complex cerebrovascular conditions. One of the most significant innovations is the development of bioactive embolic coils, which promote faster aneurysm occlusion and long-term vessel healing by encouraging endothelial cell growth. Additionally, the introduction of second-generation flow diverters with improved flexibility and flow modulation capabilities is enhancing treatment safety and effectiveness for large and wide-necked aneurysms. The integration of AI-powered imaging and robotic-assisted endovascular navigation is enabling precise embolization procedures, minimizing the risk of complications and improving patient outcomes. Liquid embolic agents with enhanced viscosity control are also advancing AVM treatment by providing better penetration and adhesion to targeted vascular structures. Moreover, the emergence of combination therapies-such as embolization followed by neuroprotective pharmacological interventions-is further optimizing neurovascular treatment strategies. As device manufacturers continue to refine embolization technologies, neurointerventional procedures are becoming safer, more efficient, and accessible to a broader patient population.

What Is Driving the Growth of the Neurovascular Embolization Devices Market?

The growth in the neurovascular embolization devices market is driven by several factors, including the rising prevalence of cerebrovascular diseases, increasing adoption of minimally invasive procedures, and continuous advancements in endovascular technology. The growing incidence of intracranial aneurysms and AVMs, fueled by aging populations and lifestyle-related risk factors such as hypertension and smoking, is creating a strong demand for effective neurovascular interventions. The shift toward minimally invasive techniques is further accelerating market expansion, as embolization procedures offer lower morbidity and shorter hospital stays compared to open surgeries. Technological advancements in embolization materials, including bioresorbable and radiopaque embolic agents, are enhancing procedural precision and safety. Additionally, the increasing availability of advanced neuroimaging techniques, such as 3D rotational angiography and perfusion MRI, is improving diagnosis and treatment planning, driving higher adoption rates. Expanding reimbursement policies and government initiatives aimed at improving stroke care infrastructure are also playing a crucial role in market growth. As healthcare providers and research institutions continue to invest in neurovascular innovation, the neurovascular embolization devices market is poised for substantial expansion, offering life-saving solutions for patients with complex cerebrovascular conditions.

SCOPE OF STUDY:

The report analyzes the Neurovascular Embolization Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Aneurysm Clips); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc. (CERENOVUS)
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc. (Terumo Corporation)
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurovascular Embolization Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Aneurysms and Stroke Cases Throws the Spotlight on Neurovascular Embolization Devices
    • Increasing Geriatric Population Base Globally Spurs Demand for Minimally Invasive Neurovascular Interventions
    • Technological Advancements in Detachable Coils and Liquid Embolic Agents Propel Market Growth
    • Development of Bioresorbable and Next-Generation Embolic Materials Expands Addressable Market Opportunity
    • Integration of AI and Image-Guided Navigation in Neurovascular Procedures Strengthens Business Case for Device Innovation
    • Growing Physician Preference for Endovascular Over Open Neurosurgery Drives Adoption of Embolization Devices
    • Government-Led Stroke Awareness Campaigns Accelerate Demand for Early Diagnosis and Intervention Tools
    • Rising Healthcare Spending in Emerging Markets Unlocks New Revenue Pools for Neurovascular Device Manufacturers
    • Increasing Hospital Investments in Hybrid Operating Rooms Creates Favorable Ecosystem for Advanced Embolization Devices
    • Surge in Interventional Neuroradiology Training Programs Sustains Growth in Skilled Workforce and Procedure Volumes
    • Rapid Shift Towards Outpatient and Ambulatory Neurosurgical Centers Spurs Demand for Compact and Easy-to-Use Devices
    • Ongoing Clinical Trials and Evidence-Based Approvals Strengthen Regulatory Confidence and Propel Commercial Uptake
    • Strategic Collaborations Between Device Companies and Academic Research Institutions Drive Innovation Pipeline
    • Increasing Reimbursement Coverage for Neurovascular Interventions Bolsters Market Accessibility and Uptake
    • Emergence of Flow Diversion Techniques as Adjunct to Embolization Expands Treatment Landscape
    • Rising Demand for Personalized Medicine Approaches Drives Interest in Customized Embolic Therapies
    • Growing Concerns Around Device Safety and Adverse Events Pose Regulatory Challenges and Slow Down Approvals
    • Increasing Use of Big Data and Predictive Analytics in Treatment Planning Enhances Clinical Outcomes and Device Use
    • Expansion of Tele-Neurointervention Capabilities in Remote Areas Propels Demand for Portable Embolization Systems
    • Advancements in 3D Printing of Neurovascular Models Facilitate Physician Training and Drive Confidence in Device Usage
    • Intensifying Competition Among Market Players Drives Pricing Pressures but Also Fuels Innovation in Product Differentiation
    • Regulatory Harmonization Across Key Markets Reduces Time-to-Market and Supports Global Expansion of Embolization Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Embolization Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolic Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Flow Diversion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Aneurysm Clips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION